Cosfroviximab (c13C6-FR1) is a chimeric monoclonal antibody derived from mouse and human sources, designed to target the Ebola virus glycoprotein (EBOV-GP) [1].
CAS Number:
[1792982-57-0]
Target:
Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted